October 24, 2017 Comments Off on Exploring Biosimilars as a Drug Patent Strategy Posted in: Insights Biologic drugs are far more complex than traditional “small molecule” drugs Generic drugs as we know them differ from biosimilars, which are designed to be less costly alternatives to branded biologic drugs.…
The post Exploring Biosimilars as a Drug Pa…
October 24, 2017 Comments Off on Using clinical trial information to forecast future therapeutic indications Posted in: Insights Drug repositioning offers an alternative path to drug development Researchers at the US drug group Pfizer’s Sandwich research center while working on an angina treatment found a compound by the…
The post Using clinical trial information to forecast fut…
